MusclePharm Ret. on assets
What is the Ret. on assets of MusclePharm?
The Ret. on assets of MusclePharm Corp. is -66.50%
What is the definition of Ret. on assets?
Return on assets indicates how profitable a company’s assets are in generating revenue. It is computed by dividing net income by average total assets.
ttm (trailing twelve months)
The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.
Ret. on assets of companies in the Consumer Staples sector on OTC compared to MusclePharm
What does MusclePharm do?
MusclePharm Corporation develops, manufactures, markets, and distributes sports nutrition products and nutritional supplements in the United States and internationally. The company offers a range of performance powders, capsules, tablets, gels, and on-the-go ready to eat snacks. Its MusclePharm brand product portfolio includes combat protein powder and combat crunch protein bars; and essential supplements, such as a BCAA, creatine, glutamine, carnitine, CLA, fish oil, multi-vitamin, and other products. The company also provides FitMiss branded sports nutrition products, which are formulated primarily for the female body to support women in the areas of weight management, lean muscle mass, body composition, and general health and wellness; and functional energy beverages under the Combat Energy and FitMiss Energy brands. It sells its products to various athletes and fitness enthusiasts. The company was incorporated in 2006 and is based in Las Vegas, Nevada.
Companies with ret. on assets similar to MusclePharm
- 96763 has Ret. on assets of -66.68%
- G Medical Innovations Ltd has Ret. on assets of -66.65%
- Deinove SA has Ret. on assets of -66.64%
- Richland Resources International has Ret. on assets of -66.59%
- Nevtah Capital Management has Ret. on assets of -66.59%
- NanoViricides Inc has Ret. on assets of -66.51%
- MusclePharm has Ret. on assets of -66.50%
- Marker Therapeutics has Ret. on assets of -66.50%
- Ri Ying has Ret. on assets of -66.47%
- Valeritas has Ret. on assets of -66.46%
- Classic Minerals has Ret. on assets of -66.40%
- NTN Buzztime Inc has Ret. on assets of -66.38%
- Nuheara has Ret. on assets of -66.30%